Renal Cancers Completed Phase 2 Trials for Atrasentan (DB06199)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00039429Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney CancerTreatment